Liverpool to trial new pancreatic cancer therapy - EurekAlert (press release)
March 15, 2007| Liverpool to trial new pancreatic cancer therapy EurekAlert (press release), DC - Pharmexa’s proprietary technology platforms are broadly applicable, allowing the company to address critical targets in cancer, rheumatoid arthritis, ... |